Cargando…
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells
The transcriptional regulator BRD4 has been shown to be important for the expression of several oncogenes including MYC. Inhibiting of BRD4 has broad antiproliferative activity in different cancer cell types. The small molecule JQ1 blocks the interaction of BRD4 with acetylated histones leading to t...
Autores principales: | Otto, C., Schmidt, S., Kastner, C., Denk, S., Kettler, J., Müller, N., Germer, C.T., Wolf, E., Gallant, P., Wiegering, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888720/ https://www.ncbi.nlm.nih.gov/pubmed/31734632 http://dx.doi.org/10.1016/j.neo.2019.10.003 |
Ejemplares similares
-
Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
por: Wang, Ranran, et al.
Publicado: (2020) -
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017) -
Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis
por: Yang, Minghua, et al.
Publicado: (2022) -
BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016) -
Acetyl-lysine Binding Site of Bromodomain-Containing
Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
por: Ember, Stuart W. J., et al.
Publicado: (2014)